Fudan University
🇨🇳China
- Country
- 🇨🇳China
- Ownership
- Private
- Established
- 1905-01-01
- Employees
- 1K
- Market Cap
- -
- Website
- http://www.fudan.edu.cn
The Combination of Immunotherapy and Stereotactic Ablative Radiotherapy in MSS Oligometastatic Colorectal Cancer
Phase 2
- Conditions
- Colorectal Cancer
- Interventions
- Radiation: Stereotactic Ablative Radiotherapy (SABR)
- First Posted Date
- 2020-09-01
- Last Posted Date
- 2021-05-11
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT04535024
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, Shanghai, China
Methylene Blue and Postoperative Neurocognitive Disorders
Not Applicable
Completed
- Conditions
- Postoperative Delirium
- Interventions
- Drug: Placebo
- First Posted Date
- 2020-08-27
- Last Posted Date
- 2025-05-14
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 314
- Registration Number
- NCT04529265
- Locations
- 🇨🇳
Shanghai Cancer Center, Fudan University, Shanghai, China
SLND or Not in cT1 GGO Invasive Lung Adenocarcinoma (ECTOP-1009)
Not Applicable
Recruiting
- Conditions
- Carcinoma, Non-Small-Cell Lung
- Interventions
- Procedure: Systematically mediastinal lymph node dissectionProcedure: No mediastinal lymph node dissection
- First Posted Date
- 2020-08-26
- Last Posted Date
- 2023-07-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 638
- Registration Number
- NCT04527419
- Locations
- 🇨🇳
Fudan University Shanghai Cancer Center, Shanghai, China
Conversion Therapy of RAS/BRAF Wild-Type Right-sided Colon Cancer Patients With Initially Unresectable Liver Metastases
Phase 3
- Conditions
- Colorectal CancerLiver Metastases
- Interventions
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 584
- Registration Number
- NCT04525326
The Prediction Model of Avastin Plus Chemotherapy in Unresectable Ras Mutant CRLM Patients
- Conditions
- Liver MetastasesColorectal Cancer
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 116
- Registration Number
- NCT04525313
Precision Medicine for Colorectal Cancer Liver Metastasis Guided by Multi-omics Data Under the Umbrella Theory
- Conditions
- Colorectal Cancer Metastatic
- Interventions
- Diagnostic Test: Multi-omics
- First Posted Date
- 2020-08-25
- Last Posted Date
- 2020-08-25
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 200
- Registration Number
- NCT04525807
Toripalimab Combined With Surufatinib for Locally Advanced Thyroid Cancer: a Phase II Study
- First Posted Date
- 2020-08-24
- Last Posted Date
- 2020-08-24
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 10
- Registration Number
- NCT04524884
- Locations
- 🇨🇳
270 Dongan Road, Fudan University Shanghai Cancer Center, Shanghai, China
Adjuvant Chemotherapy of Three-step Regimen in BRCA1/2 Wide Type Ovarian Cancer (ACTS-2)
Phase 3
Recruiting
- Conditions
- Ovarian Cancer
- Interventions
- Drug: Etoposide, Cyclophosphamide, Carboplatin/Cisplatin
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2022-07-27
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 590
- Registration Number
- NCT04520074
- Locations
- 🇨🇳
Wu Xiaohua, Shanghai, Shanghai, China
Neoadjuvant Chemotherapy With Camrelizumab in Locally Advanced Esophageal Squamous Cell
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 60
- Registration Number
- NCT04520035
- Locations
- 🇨🇳
Cancer hospital Fudan University, Shanghai, Xuhui, China
Laparoscopic Sleeve Gastrectomy Under General Anesthesia in Severely Obese Patients: a Retrospective Study
- Conditions
- Obesity
- First Posted Date
- 2020-08-20
- Last Posted Date
- 2020-08-20
- Lead Sponsor
- Fudan University
- Target Recruit Count
- 100
- Registration Number
- NCT04521543
- Locations
- 🇨🇳
Zhongshan Hospital Fudan University, Shanghai, Shanghai, China
© Copyright 2025. All Rights Reserved by MedPath